Charles S Berkman - Net Worth and Insider Trading
Charles S Berkman Net Worth
The estimated net worth of Charles S Berkman is at least $3 Million dollars as of 2024-04-28. Charles S Berkman is the SVP, Gen. Counsel & Secretary of Ligand Pharmaceuticals Inc and owns about 28,906 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $2 Million. Charles S Berkman is also the Chief Legal Officer of OmniAb Inc and owns about 292,617 shares of OmniAb Inc (OABI) stock worth over $1 Million. Details can be seen in Charles S Berkman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Charles S Berkman has not made any transactions after 2024-04-08 and currently still holds the listed stock(s).
Transaction Summary of Charles S Berkman
Charles S Berkman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles S Berkman owns 3 companies in total, including Ligand Pharmaceuticals Inc (LGND) , Avista Public Acquisition Corp II (AHPA) , and OmniAb Inc (OABI) .
Click here to see the complete history of Charles S Berkman’s form 4 insider trades.
Insider Ownership Summary of Charles S Berkman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2021-02-04 | Asso. Gen. Counsel & Secretary |
| AHPA | Avista Public Acquisition Corp II | 2022-11-01 | See Remarks |
| OABI | OmniAb Inc | 2024-04-08 | See Remarks |
Charles S Berkman Latest Holdings Summary
Charles S Berkman currently owns a total of 2 stocks. Among these stocks, Charles S Berkman owns 28,906 shares of Ligand Pharmaceuticals Inc (LGND) as of February 4, 2021, with a value of $2 Million and a weighting of 60.88%. Charles S Berkman also owns 292,617 shares of OmniAb Inc (OABI) as of April 8, 2024, with a value of $1 Million and a weighting of 39.12%.
Latest Holdings of Charles S Berkman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2021-02-04 | 28,906 | 70.57 | 2,039,896 |
| OABI | OmniAb Inc | 2024-04-08 | 292,617 | 4.48 | 1,310,924 |
Holding Weightings of Charles S Berkman
Charles S Berkman Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles S Berkman has made a total of 2 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 18,097 shares on February 4, 2021, which brought Charles S Berkman around $3 Million.
According to the SEC Form 4 filings, Charles S Berkman has made a total of 1 transactions in OmniAb Inc (OABI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in OmniAb Inc is the sale of 6,954 shares on April 8, 2024, which brought Charles S Berkman around $36,648.
Insider Trading History of Charles S Berkman
- 1
Charles S Berkman Trading Performance
GuruFocus tracks the stock performance after each of Charles S Berkman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles S Berkman is 5.7%. GuruFocus also compares Charles S Berkman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles S Berkman within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles S Berkman's insider trading performs compared to the benchmark.
Performance of Charles S Berkman
Average Return
42.78%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.2 | 5.7 | 16.41 | 42.78 | 48.35 | 31.97 |
| Relative Return to S&P 500(%) | 9.45 | 3.29 | 7.23 | 29.87 | 40.67 | 24.59 |
Charles S Berkman Ownership Network
Ownership Network List of Charles S Berkman
Ownership Network Relation of Charles S Berkman
Charles S Berkman Owned Company Details
What does Ligand Pharmaceuticals Inc do?
Who are the key executives at Ligand Pharmaceuticals Inc?
Charles S Berkman is the Asso. Gen. Counsel & Secretary of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include Chief Financial Officer Octavio Espinoza , CHIEF LEGAL OFFICER & Andrew Reardon , and CEO & President John L Higgins .
Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary
Over the past 18 months, Charles S Berkman made no insider transaction in Ligand Pharmaceuticals Inc (LGND). Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 20,000 shares made by John L Higgins , a net sale of 10,852 shares made by John W Kozarich , and a net sale of 8,301 shares made by Stephen L Sabba .
In summary, during the past 3 months, insiders sold 2,033 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 0 shares, with a net sale of 2,033 shares. During the past 18 months, 41,289 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 4,000 shares were bought by its insiders, resulting in a net sale of 37,289 shares.
Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ligand Pharmaceuticals Inc Insider Transactions
Charles S Berkman Mailing Address
Above is the net worth, insider trading, and ownership report for Charles S Berkman. You might contact Charles S Berkman via mailing address: 11085 North Torrey Pines Road, Suite 300, La Jolla Ca 92037.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
